Alexandra Mancini
General Counsel chez INMED PHARMACEUTICALS INC.
Fortune : 87 $ au 31/03/2024
Profil
Alexandra D.
J.
Mancini is the founder of True North Synergy, Inc. founded in 1999 where she holds the title of President.
She is currently the Senior VP-Clinical & Regulatory Affairs at InMed Pharmaceuticals, Inc. Alexandra's former jobs include Vice President-Regulatory Affairs at QLT, Inc. from 1996 to 1999, Senior VP-Clinical & Regulatory Affairs at Arbutus Biopharma Corp.
from 2001 to 2005, and Senior VP-Clinical & Regulatory Affairs at Sirius Genomics, Inc. from 2008 to 2012.
Alexandra received a graduate degree from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/01/2024 | 240 ( 0,00% ) | 87 $ | 31/03/2024 |
Postes actifs de Alexandra Mancini
| Sociétés | Poste | Début |
|---|---|---|
| INMED PHARMACEUTICALS INC. | General Counsel | 31/10/2016 |
True North Synergy, Inc.
 True North Synergy, Inc. Miscellaneous Commercial ServicesCommercial Services True North Synergy, Inc. is a Canadian company that provides online mortgage tools and brokers to assist with first time home buyers and investment properties. The private company is based in Vancouver, Canada and was founded by Alexandra D. J. Mancini. The company's services include a renewal reminder, mortgage checklist, and more. | Founder | 01/09/1999 |
Anciens postes connus de Alexandra Mancini
| Sociétés | Poste | Fin |
|---|---|---|
Sirius Genomics, Inc.
 Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 01/09/2012 |
| ARBUTUS BIOPHARMA CORPORATION | General Counsel | 01/06/2005 |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | General Counsel | 01/08/1999 |
Formation de Alexandra Mancini
| University of Toronto | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INMED PHARMACEUTICALS INC. | Health Technology |
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Sirius Genomics, Inc.
Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
True North Synergy, Inc.
True North Synergy, Inc. Miscellaneous Commercial ServicesCommercial Services True North Synergy, Inc. is a Canadian company that provides online mortgage tools and brokers to assist with first time home buyers and investment properties. The private company is based in Vancouver, Canada and was founded by Alexandra D. J. Mancini. The company's services include a renewal reminder, mortgage checklist, and more. | Commercial Services |
